FFF Enterprises: BioSupply Trends Newsletter
Monday, May 21, 2018

CDC OKs FluMist for 2018-19 Influenza Season


In this Issue

•  IVIG/Albumin Supply Index
•  Open Market Pricing
•  New Products from FFF
•  Current Medicare
•  Resources
•  Subscribe to IG Living and BioSupply Trends Quarterly

The Centers for Disease Control and Prevention advisory committee has voted 12-2 to recommend FluMist, the nasal spray version of the influenza vaccine, be used during the 2018-19 influenza season. [ read more ]

SCIG Therapy Is Cost-Saving Versus IVIG in Canadian Study of Primary Immunodeficiency Patients

A first-ever prospective economic analysis by Canadian investigators found that, from both hospital- and health system-based perspectives, home-based subcutaneous immune globulin (SCIG) therapy was associated with significantly lower average total nondrug costs than hospital-based intravenous immune globulin (IVIG) therapy for patients with primary immunodeficiency disorders. [ read more ]

Plasma Exchange with 5% Albumin Associated with Marked Stabilization of Brain Perfusion in Alzheimer's

Plasma exchange with 5% albumin replacement was associated with marked stabilization of brain perfusion in patients with mild to moderate Alzheimer's disease during a 21-week treatment period and reduced perfusion loss compared to control subjects at six-month follow-up. [ read more ]

With Snakebite Season in Summer, Medical Professionals Are Advised to Stock CroFab

Summer is snakebite season, and misunderstandings about proper treatment continue to subsist, not just among the general public, but among medical professionals as well. Only antivenoms can prevent or reverse most of the snakebite envenoming's effects, so it's important for healthcare facilities to have them in stock. Guidelines for stocking antivenom can be found at www.ncbi.nlm.nih.gov/pubmed/28669553 "In areas where snakebites are common, many, if not most, hospitals carry CroFab, which is used to treat pit viper bites. Pit vipers account for approximately 98 percent of bites from venomous snakes in the U.S., so it's important to have access to it," says Spencer Greene, MD, MS, FACEP, FACMT, director of the medical toxicology consultation services at Ben Taub General Hospital and Texas Children's Hospital, and a consulting toxicologist for the Southeast Texas Poison Center. [ read more ]

Industry News


From Janssen Biotech

The U.S. Food and Drug Administration has approved Erleada (apalutamide) to treat men with prostate cancer that has not yet spread but has a quickly rising PSA level while on treatment with hormone therapy, which causes concern for cancer growth and spread. [ read more ]

From Prometic Life Sciences

Prometic Life Sciences' Phase III clinical study of its intravenous immune globulin 10% product has met its primary and secondary endpoints in adult patients with primary immunodeficiencies.  [ read more ]

From Rigel

The U.S. Food and Drug Administration has approved Tavalisse (fostamatinib) to treat patients with chronic immune thrombocytopenia who have had insufficient response to another therapy. [ read more ]

IVIG & Albumin Supply Index


NEW Issue of Biosupply Trends Quarterly!

Current Issue of BSTQ

In this Issue

•  Banishing Burnout in the Healthcare Setting
•  The Evolution of Medical Aid in Dying
•  Are Drugs Really Overpriced?
•  Healthcare Data: Ensuring Regulatory Compliance
•  Myths and Facts: Cataracts

MyFluVaccine Loyalty Program

Want priority access on flu vaccines
for the 2019-2020 season?

Then take advantage of our NEW inclusive MFV Loyalty Program and enroll for the 2019-2020 season when you go to book your flu vaccine orders for the 2018-2019 season through MyFluVaccine.com

  • Priority access on advance released flu vaccines
  • No minimum purchase
  • Hassle-free
  • Guaranteed booking for the products you need

What's New at FFF


HEPLISAV-B (hepatitis B vaccine [recombinant] adjuvanted) is indicated in adults ages 18 and older for prevention of infection caused by all known subtypes of hepatitis B virus. It is supplied in 0.5 mL single-dose vials.

For more information about HEPLISAV-B, login to biosupply.fffenterprises.com


REBINYN (glycoPEGylated) is a recombinant DNA-derived coagulation factor IX concentrate indicated for use in adults and children with hemophilia B for on-demand treatment and control of bleeding episodes and perioperative management of bleeding. It is available as a lyophilized powder in single-use vials of 500, 1,000 and 2,000 IU.

For more information about REBINYN, login to biosupply.fffenterprises.com

These products can be ordered from FFF Enterprise's BioSupply Online Ordering System or by calling
Wow! Customer Care at (800) 843-7477.

Current Medicare IVIG / SCIG Rates

Rates per gram are effective Apr. 1, 2018, through Jun. 30, 2018.

Product J Codes ASP + 6%
(before sequester)
ASP + 4.3%*
(after sequester)
Carimune NF J1566 $71.06 $69.92
Flebogamma J1572 $70.29 $69.16
Gammagard S/D J1566 $71.06 $69.92
Gammaplex J1557 $78.19 $76.93
Octagam J1568 $82.81 $81.49
Privigen J1459 $79.30 $78.03
CUVITRU J1555 $135.25 $133.08
Hizentra J1559 $98.33 $96.75
HyQvia J1575 $138.59 $136.37
Gammagard Liquid J1569 $79.38 $78.10
Gammaked J1561 $78.29 $77.03
Gamunex-C J1561 $78.29 $77.03

*Reflects 2% sequestration reduction applied to 80% Medicare payment portion as required under Budget Control Act of 2011.



FFF customers may order the following complementary resources to help you with your practice:

•  IG Immune Globulin (Human)
•  Hyperimmune Globulins
•  Anti-Inhibitor, Factor VIIa & IX
•  Factor VIII & von Willebrand Factor
•  Seasonal Influenza Vaccine

Subscribe to IG Living

IG Living is the only magazine for the immune globulin (IG) community for patients who suffer from chronic illness and their caregivers.

Subscribe to BioSupply
Trends Quarterly

BioSupply Trends Quarterly magazine is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace.

Home | About | Advertise | Subscribe | Contact – ©2018 FFF Enterprises, Inc.
This email was sent by: %%Member_Busname%%, %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
Manage preferences: Privacy Policy, Update Profile, Unsubscribe.